GLINE MATTHEW enters ARBUTUS BIOPHARMA CORP with 38.85M shares across direct and indirect positions
This filing by GLINE MATTHEW establishes the baseline for all future Form 4 insider transaction reports at ARBUTUS BIOPHARMA CORP.
Indirect
Filed: 3/6/2025ACC: 0001447028-25-000059
Director10% Owner
Since Feb 2025
38.85M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
38.85M indirect
Non-Derivative Holdings1
Common Shares
IndirectShares owned38.85M
Total
38.85M indirect38.85M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 38.85M | Indirect |
| Total | 38.85M | 38.85M indirect |
Derivative Holdings0
No derivative holdings reported